Constitution Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,300
Closed -$207K 60
2025
Q1
$207K Buy
+2,300
New +$206K 0.11% 59
2024
Q4
Sell
-2,800
Closed -$252K 60
2024
Q3
$252K Sell
2,800
-700
-20% -$58.9K 0.13% 51
2024
Q2
$275K Sell
3,500
-100
-3% -$8.2K 0.15% 56
2024
Q1
$314K Sell
3,600
-200
-5% -$17.1K 0.18% 50
2023
Q4
$313K Sell
3,800
-1,950
-34% -$149K 0.19% 45
2023
Q3
$451K Sell
5,750
-600
-9% -$50.2K 0.31% 37
2023
Q2
$559K Sell
6,350
-100
-2% -$8.61K 0.32% 34
2023
Q1
$520K Sell
6,450
-100
-2% -$8.15K 0.32% 38
2022
Q4
$509K Buy
+6,550
New +$531K 0.31% 40

Other funds holding MDT

Constitution Capital's MDT Position: Q2 2025 in Review

Constitution Capital sold out of Medtronic (MDT) in Q2 2025, closing a stake of 2,300 shares — an estimated $207K sold.

Constitution Capital first reported a position in MDT in Q4 2022 and held it in 9 quarters. The position peaked at $559K in Q2 2023. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Constitution Capital reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Constitution Capital sold 2,300 Medtronic shares in Q2 2025, an estimated $207K.
  • Constitution Capital first reported a position in Medtronic in Q4 2022 and held it in 9 quarters.
  • Constitution Capital's Medtronic position peaked at $559K in Q2 2023.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Constitution Capital's 13F filing for Q2 2025, filed 13 Aug 2025.